Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-04-16

FDA Approved: LORATADINE — Original Application (Chain Drug Consortium, LLC)

View source ↗

Summary

The FDA approved the original application for loratadine filed by Chain Drug Consortium, LLC, enabling a generic loratadine product to be marketed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Loratadine (Loratadine)

Snippet

ORIG AP for LORATADINE (LORATADINE)